Zentiva’s Post

Wataru Momose, Ph.D. (Dr. Momo), Ph.D., Director of Business Strategy, Otsuka Pharmaceutical Co., Ltd. Co Contributed an article "Insights into Healthcare Ecosystem" "In applying this mindset to disrupt the healthcare industry ecosystem, we can unite leaders from various industries, each with unique perspectives, while aligning with the shared goal of reducing medical costs and increasing healthy life expectancy."says Wataru Momose, Ph.D. The article will also be featured in the forthcoming special print edition on Pharma Consulting 2024. Read More: https://shorturl.at/hlpV1 #medicalcosts #healthcareindustry #pharmaceuticalcompanies #drugdiscovery

The importance of diversity in fostering innovation, especially in the healthcare industry, cannot be overstated. It accelerates the pace of progress, as diverse perspectives contribute to unique and effective solutions. Building a team with diverse members, including those with different and unique industrial leadership backgrounds, is therefore a crucial strategy for success. 異なる考え方や専門性を持った方をRespectし、一つのShared objectiveに向かって個々人が活躍するチームビルディングこそ、ヘルスケア業界のイノベーションに繋がると信じます。 #diversityandinclusion #leadership #healthcareinnovation #healthcareindustry

We're thrilled to announce that EUROPACCESS - Your Pharma Partner will participate in Bio San Diego from June 3rd - 6th! We'll be hosted by the German Pavilion, and we can't wait to connect with you there. Are you a company looking to expand your access to European markets? Look no further! EUROPACCESS is your single partner solution for navigating the complexities of European market entry. Our extensive network spans Western, Central, and Eastern Europe, offering you a gateway to key markets including the UK, Spain, France, Germany, and Italy. In total, we cover 30+ countries in the region. At EUROPACCESS - Your Pharma Partner, we are experts in coordinating Early/Expanded Access Patient programs for innovative medicines, as well as in the marketing of registered pharmaceuticals. Our in-house teams provide comprehensive support from the initial stages of the drug lifecycle to obtaining reimbursement (where applicable), ensuring your product’s successful launch and commercialization. Don't miss this opportunity to meet us at Bio San Diego and learn how EUROPACCESS can accelerate your market access strategy! See you there! #BIO2024 #BioSanDiego #EUROPACCESS #MarketAccess #EuropeanMarkets #Innovation #ExpandedAccess #Biotech #Pharma #Healthcare

👉 Healthcare isn’t just a necessity; it’s a celebration of life. In the landscape of pharmaceutical excellence, only a few names resonate with the same level of trust and influence. With a history spanning over five decades, Angelini Pharma España chronicles just not a tale of corporate grandeur; but weaves a narrative of healthcare legacy. 👉 Today, with nearly 200 dedicated employees and a turnover exceeding 84 million euros in 2022, the company’s impact on the Spanish pharmaceutical landscape is profound and indelible.Olga Insua, General Manager for Spain and Portugal, is leading the company toward a future where healthcare transcends borders. 👉 Under the astute leadership of Olga Insua, General Manager of Angelini Pharma España and General Manager Ad Interim for Angelini Pharma Portugal, the company continues to soar to new heights. Visit More : https://lnkd.in/dRJZDQsb #healthcare #pharmaceutical #growth #innovation #methodology  

➡ A 2024 MARKET ACCESS TREND DEMANDING ATTENTION ⬅ In last month's many lists of pricing and market access trends for 2024, one topic was notably absent: #clawbacks. As policy makers grapple with healthcare- and pharmaceutical budget overruns, they are increasingly turning to clawbacks and mandatory rebates as solutions. This trend is reshaping the pricing and market access landscape across markets, with profound implications for pharmaceutical companies and health systems. Join our Pricing Panel during the World Evidence, Pricing and Access Congress, during which Inbeeo and esteemed panellists will explore: 📈 The evolution of clawbacks and mandatory rebates ⚠ The implications for #marketaccess and pricing teams 🍃 The future of clawbacks in our joint quest to make health systems more sustainable 📅 Tuesday 12 March ⏲ 14.05hrs #EPAConf #pharmaceuticals #patientaccess #healthsystems #sustainability

🌟CALLING ALL PHARMACEUTICAL PROFESSIONALS! Join us at the WOCIP Cluster Meetings, where collaboration sparks innovation! See the exciting topics covered in all four targeted business meetings below! Stay tuned as we unveil the unique topics for each day! Join forces with peers in your role across the industry to tackle barriers to health equity together! 🌎 REGISTER BY APRIL 12th AND GET 50% OFF. Use the link and code in the comments. #WOCIP #HealthEquity #PharmaIndustry

🔎 White paper: Overcoming Pharma's Value and Access Challenges Discover how to embed operational excellence in Value and Access to overcome the challenges pharma companies now face in the following areas: ➡️ Demonstrating Value ➡️ Obtaining a Price that Rewards Innovation ➡️ Negotiating with Unified Payers and HTAAs 📥 Download your free copy of the white paper here: https://lnkd.in/eSXQzC8e #Pharma #Pharmaceuticals #PharmaceuticalStrategy #Biopharma #Strategy #Consulting #OperationalExcellence #ValueandAccess #MarketAccess #Innovation #Pricing

💡 Did you know? Up to 46% of pharmaceutical product launches don't fully hit their targets, because strategies aren't aligned with patient needs and the complexities of their healthcare journey. Launching a pharmaceutical product comes with its set of hurdles, and there's much to be learned from the industry's past challenges. Our research underscores the importance of a nuanced understanding of the market and patient journeys, revealing that nearly half of all launches must be improved in these areas. This insight is an encouragement for the industry to invest in comprehensive market research and detailed patient journey analyses. Doing so paves the way for launch strategies that do more than just reach their audience—they genuinely engage and provide value to patients in search of effective treatments. By drawing on the lessons from previous launches, we have the opportunity to refine our approach, creating more impactful connections with patients and driving innovation in healthcare to new heights. ✅ Learn more: https://lnkd.in/djtgYUrG #druglaunch #marketinsights #patientjourney #healthcareinnovation

📢 EPC Highlights | 5 Recommendations for the Pharmaceutical Sector by Elizabeth Kuiper Following Elizabeth Kuiper's recent participation at the Euronews Health Summit together with Gloria Ghéquière and Olivier Girard where she took took part in a panel about critical medicines, we're pleased to share a video highlighting EPC's 5 key recommendations for the pharmaceutical sector in Europe. These insights are especially relevant in the context of the EPC's work on Economic Security. Learn more here 👉 https://lnkd.in/eqRDU88Z Paweł Świeboda Danielle Brady Madda Henry Magbity Wael Maâninou Kel Nkondock Tyana Barry Astraia Begeer Jeremy Fleming Monica Robles Méabh Mc Mahon Andrianos Giannou #Pharmaceuticals #EconomicSecurity #HealthPolicy

Global excellence - local execution. That's what we do at Simon-Kucher. We specialize in crafting pharmaceutical market access strategies that seamlessly balance global ambitions with local execution. Check out our full insights on a better market access, register for our newsletter and learn to navigate the intricate trade-offs of price, access, and time to ensure optimal market penetration and rapid reimbursement. skp.link/toa #BetterMarketAccess #Healthcare #Pharma #SImonKucher